苯并巴比妥

苯并巴比妥（CAS 744-80-9）的独立参考数据，整理自公开化学数据库。

各数据库的登记标识

计算分子描述符

在册的记载用途

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

同义词与商品名

Benzobarbital; 744-80-9; Benzonal; Benzoylluminal; Benzonalum; Benzobarbitalum; 1-Benzoyl-5-ethyl-5-phenylbarbituric acid; DTXSID1046138; YNJ78BD0AH; 5-Ethyl-1-benzoyl-5-phenylbarbituric acid; DTXCID9026138; RefChem:118260; Benzoylphenobarbital; Benzoyluminal; 1-benzoyl-5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione; Benzobarbital [INN]

公开数据库对它的描述

benzobarbital · CAS 744-80-9 · C19H16N2O4. UNII YNJ78BD0AH.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。